Micafungin SodiumThird Party Manufacturing in India

Micafungin Sodium works by non-competitively inhibiting the synthesis of 1,3-beta-D-glucan, an essential component of the fungal cell wall. It disrupts fungal cell wall integrity to help the body eliminate invasive fungal pathogens through osmotic instability and lysis. Unlike azole antifungals, it targets structural cell wall elements rather than cell membrane sterols, mitigating many common drug-drug interactions. It is highly effective and well-tolerated in immunocompromised patients.

Therapeutic Uses

• Invasive Candidiasis: Treatment of systemic Candida infections including candidemia.
• Esophageal Candidiasis: Resolution of severe fungal infections in the esophagus.
• Prophylaxis of Candida Infections: Prevention of fungal outbreaks in hematopoietic stem cell transplant recipients.

Why Manufacturers Choose Micafungin Sodium

As a premium echinocandin, this molecule enjoys robust demand in critical care and oncology setups due to low resistance rates. Launching Micafungin Sodium third party manufacturing in India allows distributors to capture a highly specialized, margin-resilient therapeutic segment. Utilizing our extensive network, our production facilities are WHO-GMP certified to carefully manage the delicate lyophilization process necessary to secure the stability and long shelf-life of this life-saving antifungal agent under various climatic zones.